Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV - Post by User

<< Previous
Bullboard Posts
Next >>
Post by DrJayseron Mar 29, 2023 11:12am
318 Views
Post# 35366915

Running on Fumes....HAHAHAHAHA!!!!!!!

Running on Fumes....HAHAHAHAHA!!!!!!!

 announced “Securities for Services” agreements with Top Meadow Consulting Services Inc. and Mr. Graham Burton, the Company has issued an aggregate of 507,345 common shares in the capital of the Company (the “Shares”) to Top Meadow Consulting Services Inc. and Mr. Graham Burton.

The deemed price per Share and the number of Shares to be issued pursuant to the Agreements were determined as of a date after the applicable services were provided to the Company, and was determined using the Discounted Market Price (as such term is defined in the policies of the TSX Venture Exchange) of the Shares on the TSXV on the date immediately preceding the issuance. In particular:

https://stockhouse.com/news/press-releases/2023/03/28/avivagen-inc-provides-update-on-securities-for-service-agreements-with-ceo-and

<< Previous
Bullboard Posts
Next >>